FirsthandHealth
medRxiv PreprintsInternational16 November 2026

Beyond prescription: Determinants of low-dose aspirin adoption and uptake across the pre-eclampsia prevention pathway in Nepal - a qualitative study guided by the COM-B model

This is an official announcement record

Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.

Despite strong evidence supporting low-dose aspirin (LDA) for preventing pre-eclampsia among women at risk, implementation remains suboptimal globally. The prevention pathway encompasses early antenatal care engagement, screening and risk identification, prescribing LDA, and medication uptake. This qualitative study explored barriers and facilitators to LDA adoption by providers (i.e., prescribing) and uptake among women in Nepal. A qualitative study was conducted with pregnant women, healthcare providers, and maternal and child health stakeholders in Nepal. Data collection and analysis were g
Source: medRxiv Preprints
Read the official announcement

Opens www.medrxiv.org

More from medRxiv Preprints

This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.